Chris Gugl

Chris Gugl has over 8 years of work experience in the healthcare industry. In 2013, they began working at Helbling Technik AG as Head of Integrated Care. In 2018, they became an Advisor at PharmaBiome AG, a pre-clinical microbiome company. Chris then co-founded Collabree AG, a digital adherence start-up, in 2020. In 2021, they co-founded and became an Executive Board Member at WINGS Health, Carity, SIVA Health, and Therayou. In 2022, Chris Gugl began working as a Lecturer in MAS digital Clinical Research at ETH Zürich and Co-Founder and Executive Board Member at Albatross Care.

Chris Gugl completed a Master of Science (MSc) in Biomedizintechnik/Medizintechnik from ETH Zürich and an Executive MBA from the University of St.Gallen in 2017.